Cervical cancer screening policies and coverage in Europe

European Journal of Cancer

Volumn 45, Issue 15, 2009, Pages 2649-2658

  Anttila, Ahti ^a   von Karsa, Lawrence ^b   Aasmaa, Auni ^c   Fender, Muriel ^d   Patnick, Julietta ^e,f   Rebolj, Matejka ^g   Nicula, Florian ^h   Vass, Laszlo ⁱ   Valerianova, Zdravka ^j   Voti, Lydia ^b   Sauvaget, Catherine ^b   Ronco, Guglielmo ^k  

^a FINNISH CANCER REGISTRY   (Finland)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c Estonian Cancer Center   (Estonia)

^d Association EVE   (France)

^e NATIONAL HEALTH SERVICE   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h THE ONCOLOGY INSTITUTE PROF DR ION CHIRICUTA   (Romania)

ⁱ Department of Pathology   (Hungary)

^j Bulgarian Cancer Registry   (Bulgaria)

^k Center for Cancer Prevention CPO Piemonte   (Italy)

more..

Author keywords

Cervix uteri; Epidemiology; Evaluation; Monitoring; Policy; Screening

Indexed keywords

ARTICLE; CANCER REGISTRY; CANCER SCREENING; CONTROLLED STUDY; EUROPEAN UNION; GROUPS BY AGE; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH EDUCATION; HEALTH PROGRAM; INTERPERSONAL COMMUNICATION; POPULATION RESEARCH; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

ADULT; AGED; EARLY DETECTION OF CANCER; EUROPE; FEMALE; HEALTH POLICY; HUMANS; MASS SCREENING; MIDDLE AGED; QUESTIONNAIRES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 70349171044     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.07.020     Document Type: Article

References (45)

1. International Agency for Research on Cancer. Screening for cancer of the uterine cervix. From the IARC working group on cervical cancer screening and the UICC project group on the evaluation of screening programmes for cancer. IARC Sci Publ; 1986. p. 1-315.
2. International Agency for Research on Cancer. IARC/WHO handbooks of cancer prevention: cervix cancer screening, vol. 10. Lyon: IARC Press; 2005. p. 1-302.
3. Hakama M. Trends in the incidence of cervical cancer in the Nordic countries. In: Magnus K. (Ed). Trends in cancer incidence (1982), Hemisphere Publishing Corporation, Washington 279-292
4. Magnus K., Langmark F., and Andersen A. Mass screening for cervical cancer in Ostfold county of Norway 1959-77. Int J Cancer 39 (1987) 311-316
5. Nieminen P., Kallio M., Anttila A., and Hakama M. Organised versus spontaneous pap-smear screening for cervical cancer, a case-control study. Int J Cancer 83 (1999) 55-58
6. Lynge E. Cohort studies in evaluation of cervical cancer screening. In: Sankila R, Demaret E, Hakama M, Lynge E, Schouten LJ, Parkin DM, editors. Evaluation and monitoring of screening programmes. Europe against Cancer Programme, Brussels, Luxemburg; 2000. p. 119-31.
7. Ronco G., Pilutti S., Patriarca S., et al. Impact of the introduction of organised screening for cervical cancer in Turin, Italy: cancer incidence by screening history 1992-98. Brit J Cancer 93 (2005) 376-378
8. Breitenecker G., Dinges H.P., Regitnig P., Wiener H., and Vutuc C. Cytopathology in Austria. Cytopathology 15 (2004) 113-118
9. Busuttil R., Dalmas M., and Cilia Vicente A. Effectiveness of opportunistic screening for cancer of the cervix uteri. Malta Med J 18 (2006) 15-20
10. van Ballegooijen M., van den Akker-van Marle E., Patnick J., et al. Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness. Eur J Cancer 36 (2000) 2177-2188
11. Anttila A, Ronco G, Lynge E, et al. Epidemiological guidelines for quality assurance in cervical cancer screening. In: Arbyn M, Anttila A, Jordan J, et al., editors. European guidelines for quality assurance in cervical cancer screening (2nd ed.). Luxembourg: Office for Official Publications of the European Communities; 2008. p. 11-68 [chapter 2].
12. Coleman D., Day N., Douglas G., et al. European guidelines for quality assurance in cervical cancer screening. Europe against cancer programme. Eur J Cancer 29A Suppl 4 (1993) S1-S38
13. Council of the European Union. Council Recommendation of 2 December 2003 on cancer screening (2003/878/EC). Off J Eur Union 2003;L327:34-8.
14. Advisory Committee on Cancer Prevention & Lynge E. Recommendations on cancer screening in the European Union. Advisory Committee on Cancer Prevention. Eur J Cancer 2000;36:1473-78.
15. In: Arbyn M., Anttila A., Jordan J., et al. (Eds). European guidelines for quality assurance in cervical cancer screening. 2nd ed. (2008), Office for Official Publications of the European Communities, Luxembourg
16. Ronco G., van Vallegooijen M., Becker N., et al. Process performance of cervical screening programmes in Europe. Eur J Cancer 45 15 (2009) 2659-2670
17. De Vuyst H., Clifford G., Li N., and Franceschi S. HPV in Europe. Eur J Cancer 45 15 (2009) 2632-2639
18. Arbyn M., Raifu A.O., Weiderpass E., Bray F., and Anttila A. Trends of cervical cancer mortality in the Member States of the European Union. Eur J Cancer 45 15 (2009) 2640-2648
19. Arbyn M., Rebolj M., De Kok I., et al. The challenges of organising cervical screening programmes in the 15 old member states of the European Union. Eur J Cancer 45 15 (2009) 2671-2678
20. Nicula F.A., Anttila A., Neamtiu L., et al. Challenges in starting organised screening programmes for cervical cancer in the new member states. Eur J Cancer 45 15 (2009) 2679-2684
21. Lévy-Bruhl D., King L.A., O' Flanagan D., et al., and the country specific VENICE gate keepers and contact points. The current state of introduction of HPV vaccination into national immunisation schedules in Europe: results of the VENICE 20*08 survey. Eur J Cancer 45 15 (2009) 2709-2714
22. Lynge E., Anttila A., Arbyn M., Segnan N., and Ronco G. What's next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccination. Eur J Cancer 45 15 (2009) 2714-2721
23. Working group on the registration and monitoring of cervical cancer screening programmes in the European Union. Description of the national situation of cervical cancer screening in the member states of the European Union. Eur J Cancer 2009;45(15):2685-708.
24. Curado MP, Edwards B, Shin HR, et al., editors. Cancer incidence in five continents, vol. IX. IARC Scientific Publications No. 160. Lyon: IARC; 2007. .
25. von Karsa L, Anttila A, Ronco G, et al. Cancer screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening, First report. Luxembourg; European Communities: 2008. p. 1-136.
26. Ronco G, von Karsa L, Anttila A. Key performance indicators. In: Arbyn M, Anttila A, Jordan J, et al., editors. European guidelines for quality assurance in cervical cancer screening (2nd ed.). Brussels, Luxembourg: European Community, Office for Official Publications of the European Communities; 2008. p. 231-42 [chapter 7].
27. Linos A., Riza E., and van Ballegooijen M. Introduction: cervical cancer screening. Eur J Cancer 36 (2000) 2175-2176
28. Anttila A., Ronco G., Clifford G., et al. Cervical cancer screening programmes and policies in 18 European countries. Br J Cancer 91 (2004) 935-941
29. Kyrgiou M., Koliopoulos G., Martin-Hirsch P., et al. Obstetric outcomes after conservative treatment for intra-epithelial or early invasive cervical lesions: a systematic review and meta-analysis of the literature. Lancet 367 (2006) 489-498
30. Albrechtsen S, Rasmussen S, Thoresen S, Irgens LM, Iversen OE. Pregnancy outcome in women before and after cervical conisation: population based cohort study. BMJ 2008;337:a1343. doi:10.1136/bmj.a1343.
31. Bray F., Loos A.H., McCarron P., et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomark Prev 14 (2005) 677-686
32. Karim-Kos HE, de Vries E, Soerjomataram I, et al. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008;44(10):1345-89 [Epub 2008 February 14].
33. Anttila A., and Nieminen P. Cervical cancer screening programme in Finland with an example on implementing alternative screening methods. Col Antropol 31 Suppl 2 (2007) 17-22
34. Rebolj M., van Ballegooijen M., Berkers L.M., and Habbema D. Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands. Int J Cancer 120 (2007) 806-812
35. Van der Aa M.A., Pukkala E., Brinkhuis M., et al. Mass screening programmes in relation to trends in incidence and mortality of cervical cancer between Finland and the Netherlands. Int J Cancer 122 (2008) 1854-1858
36. Rebolj M., van Ballegooijen M., van Kemenade F., et al. No increased risk for cervical cancer after a broader definition of a negative Pap smear. Int J Cancer 123 (2008) 2632-2635
37. Rousseau A, Bohet P, Merlière J, et al. Evaluation du dépistage organisé et du dépistage individuel du cancer du col de l'utérus: utilité des données de l'Assurance maladie bulletin épidémiologique h4ebdomadaire 2002;19:81-83 (in French).
38. Scheiden R., Wagener C., Knolle U., et al. Cervical cancer screening in Luxembourg: 1990-1999. Cytopathology 14 (2003) 235-240
39. Arbyn M, van Oyen H. Analysis of individual health insurance data pertaining to Pap smears, colposcopies, biopsies and surgery on the uterine cervix (Belgium, 1996-2000). IPH/EPI-REPORTS 21. Brussels: Scientific Institute of Public Health; 2004. p. 1-100.
40. Tachezy R., and Rob L. Cervical cancer screening in the Czech Republic. Coll Antropol 31 Suppl 2 (2007) 27-29
41. European Parliament. European Parliament resolution of 10 April on combating cancer in the enlargened European Union. P6_TA-PROV(2008)0121.
42. Council of the EU. Council Conclusions on reducing the burden of cancer. 2876th Employment, Social Policy, Health and Consumer Affairs Council meeting. LUXEMBOURG, 10 June 2008. Brussels, Belgium: Press Office of the Council of the European Union; 2008. press.office@consilium.europa.eu, .
43. European Commission: report from the Commission to the Council, the European Parliament, the European Economic and Social Committee and the Committee of the Regions. Implementation of the Council Recommendation of 2 December 2003 on cancer screening (2003/878/EC). Commission of the European Communities, Brussels, 22.12.2008. COM(2008) 882 final.2008.
44. Monto K, Nieminen P. Gynekologisten irtosolunäytteiden määrät ja raportointitavat Suomessa. Suomen Lääkärilehti 2005;60:2093-7 (in Finnish).
45. Duport N. Données épidémiologiques sur le cancer du col de l'uterus. Ètat des connaissances - Actualisation 2008. Paris Mai: Institut de Veille Sanitaire; 2008. p. 1-31.